Redefining Efficiency: Intensified and Continuous Processing in Action

Process intensification and continuous bioprocessing are moving from pilot studies to commercial implementation as companies seek to increase productivity, reduce facility footprint, and enable more flexible manufacturing operations. This workshop will explore real-world experiences deploying intensified upstream processes, continuous downstream platforms, and integrated end-to-end manufacturing strategies. Speakers will share lessons learned in scaling these approaches, the analytical challenges involved, and how companies are adapting facility design, process control strategies, and regulatory frameworks to support continuous operations.

Transforming Biomanufacturing Through Digital Innovation

Digital technologies are rapidly transforming how biologics are developed and manufactured, enabling companies to move beyond fragmented data systems toward more integrated, intelligent bioprocessing environments. Advances in artificial intelligence, machine learning, advanced analytics, and digital twins are helping organizations accelerate process development, improve process understanding, and enhance manufacturing efficiency across the bioprocess lifecycle. In this plenary session, industry leaders will share how companies across the Asia-Pacific region are implementing digital strategies to connect development and manufacturing data, support predictive process control, and build more scalable, data-driven biomanufacturing operations.

AI-Driven Decision Making in Process Development - From Trial-and-Error to Predictive Development

Artificial intelligence and advanced data analytics are transforming process development from traditional empirical experimentation into predictive, model-driven optimization. By leveraging machine learning algorithms, digital twins, and integrated process models, organizations can accelerate development timelines, improve process robustness, and enhance scale-up predictability. This session will highlight how companies are applying AI to guide cell culture optimization, predict downstream performance, and streamline process design. Speakers will present real-world case studies demonstrating measurable gains in productivity, yield, and speed to clinic, while also addressing the practical challenges of implementing AI tools within established development workflows.

Advanced Analytics & Process Analytical Technology - Real-Time Process Insight with Advanced Analytics

Advanced analytical tools and Process Analytical Technology (PAT) are playing a critical role in improving process understanding, enabling real-time monitoring, and supporting more consistent manufacturing outcomes. As biologics manufacturing processes become increasingly complex, organizations are deploying next-generation analytical technologies to gain deeper insight into process performance and product quality. This session will explore how companies are implementing advanced analytics, multi-attribute methods, and real-time monitoring tools across development and manufacturing operations. Speakers will share case studies demonstrating how PAT-enabled strategies can accelerate development timelines, improve process control, and support regulatory expectations for data-driven manufacturing.

Overcoming Challenges in Developing Novel Modalities - Manufacturing the Next Generation of Biologics

The rapid emergence of novel biologic modalities is introducing new challenges across process development, manufacturing, and analytical characterization. These advanced molecules often require specialized expression systems, purification strategies, and analytical methods to ensure product quality and scalability. This session will bring together experts who have successfully advanced these complex biologics through development and into clinical or commercial manufacturing. Speakers will share lessons learned, highlight technical hurdles encountered along the way, and discuss strategies for establishing robust, scalable processes for next-generation therapeutics.

Digitalization in CMC, MSAT & Tech Transfer - Connecting Development to Manufacturing Through Data

Digital manufacturing technologies are transforming how biologics processes are monitored, controlled, and optimized within GMP production environments. By combining real-time analytics, advanced control strategies, and integrated data platforms, companies are achieving improved process consistency, reduced deviations, and enhanced manufacturing efficiency. This session will examine how digital tools are being successfully deployed in commercial manufacturing facilities. Speakers will present case studies illustrating how these technologies are bridging development models with manufacturing execution systems to deliver more reliable and data-driven biomanufacturing operations.